Royal Veterinary College, University of London, London, UK.
Endocr Relat Cancer. 2012 Jan 9;19(1):C1-5. doi: 10.1530/ERC-11-0297. Print 2012 Feb.
Angiogenic markers in pituitary adenomas remain enigmatic in terms of their function in tumorigenesis, despite being upregulated by the normal physiological trigger of hypoxia. In this issue of Endocrine-Related Cancer, Shan et al. report that the novel RWD domain containing protein, RWD-containing sumoylation enhancer, is expressed in human pituitary adenomas and plays a pivotal role in regulating the hypoxia-inducible factor 1α-vascular endothelial growth factor response to hypoxia.
尽管血管生成标记物在肿瘤发生过程中受到正常生理缺氧触发的上调,但它们在垂体腺瘤中的功能仍然是神秘的。在本期《内分泌相关癌症》杂志中,Shan 等人报告称,新型 RWD 结构域包含蛋白 RWD 包含 SUMO 修饰增强子在人类垂体腺瘤中表达,并在调节缺氧诱导因子 1α-血管内皮生长因子对缺氧的反应中发挥关键作用。